FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2010438139> ?p ?o ?g. }

• W2010438139 endingPage "1725" @default.
• W2010438139 startingPage "1718" @default.
• W2010438139 abstract "BACKGROUND: The A118G polymorphism of the mu-opioid receptor gene (OPRM1), resulting in the substitution of an amino acid, has been found to be associated with functional effects and response to opioid treatment. The purpose of this study was to assess whether this polymorphism contributes to the variability in response to tramadol/acetaminophen combination tablets (Ultracet) for treating oxaliplatin-induced painful neuropathy. METHODS: A total of 96 patients with adenocarcinoma of the colon or rectum (n = 84), or stomach (n = 12) who had developed oxaliplatin-induced painful neuropathy were enrolled. Ultracet was administered at 1 tablet every 6 hours, and pain was assessed and scored using a visual analog scale (VAS). The OPRM1 A118G polymorphism was examined with a polymerase chain reaction-direct sequencing method. RESULTS: The allelic frequency of variant (118G) allele was 39.6%, and the prevalence of OPRM1-118 AA, AG, and GG genotypes was 31.3% (n = 30), 58.3% (n = 56), and 10.4% (n = 10), respectively. For all patients, the mean pre-treatment and post-treatment VAS scores were 3.1 and 2.1, respectively (P < .001). Patients with AA genotype had a better analgesic effect than those with G allele variants (AG or GG genotypes). Pre-treatment and post-treatment VAS scores for patients with G allele variants were 3.1 and 2.6, respectively; however, for patients with AA genotype, pre-treatment and post-treatment VAS scores were 3.0 and 0.9, respectively (P < .001). The requirement for rescue analgesia was also higher for patients with G allele variants (P = .01). CONCLUSIONS: These data suggest that Ultracet is effective in the management of oxaliplatin-induced painful neuropathy. A118G polymorphism of OPRM1, by altered function of the mu-opioid receptor and consequential analgesic effect on opioid agents, could be a key determinant for decreased response to Ultracet. Cancer 2011;. © 2011 American Cancer Society." @default.
• W2010438139 created "2016-06-24" @default.
• W2010438139 creator A5064426920 @default.
• W2010438139 creator A5078658316 @default.
• W2010438139 date "2011-08-11" @default.
• W2010438139 modified "2023-09-26" @default.
• W2010438139 title "Human mu-opioid receptor gene A118G polymorphism predicts the efficacy of tramadol/acetaminophen combination tablets (ultracet) in oxaliplatin-induced painful neuropathy" @default.
• W2010438139 cites W1968814844 @default.
• W2010438139 cites W1972015478 @default.
• W2010438139 cites W1974645621 @default.
• W2010438139 cites W1975262853 @default.
• W2010438139 cites W1976013534 @default.
• W2010438139 cites W1982081545 @default.
• W2010438139 cites W1993188399 @default.
• W2010438139 cites W2005660221 @default.
• W2010438139 cites W2006613730 @default.
• W2010438139 cites W2012743573 @default.
• W2010438139 cites W2013187174 @default.
• W2010438139 cites W2014405410 @default.
• W2010438139 cites W2020205310 @default.
• W2010438139 cites W2022797906 @default.
• W2010438139 cites W2025201785 @default.
• W2010438139 cites W2031555481 @default.
• W2010438139 cites W2035062443 @default.
• W2010438139 cites W2037789787 @default.
• W2010438139 cites W2045730050 @default.
• W2010438139 cites W2047737161 @default.
• W2010438139 cites W2047822028 @default.
• W2010438139 cites W2049583185 @default.
• W2010438139 cites W2051364130 @default.
• W2010438139 cites W2060855217 @default.
• W2010438139 cites W2061254685 @default.
• W2010438139 cites W2063017492 @default.
• W2010438139 cites W2066582161 @default.
• W2010438139 cites W2072820550 @default.
• W2010438139 cites W2076664459 @default.
• W2010438139 cites W2077348241 @default.
• W2010438139 cites W2080253238 @default.
• W2010438139 cites W2082143935 @default.
• W2010438139 cites W2084268808 @default.
• W2010438139 cites W2085394272 @default.
• W2010438139 cites W2085930219 @default.
• W2010438139 cites W2104786490 @default.
• W2010438139 cites W2117636258 @default.
• W2010438139 cites W2142338863 @default.
• W2010438139 cites W2143552539 @default.
• W2010438139 cites W2148447733 @default.
• W2010438139 cites W2148622949 @default.
• W2010438139 cites W2150700020 @default.
• W2010438139 cites W4231481744 @default.
• W2010438139 doi "https://doi.org/10.1002/cncr.26430" @default.
• W2010438139 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21837673" @default.
• W2010438139 hasPublicationYear "2011" @default.
• W2010438139 type Work @default.
• W2010438139 sameAs 2010438139 @default.
• W2010438139 citedByCount "43" @default.
• W2010438139 countsByYear W20104381392012 @default.
• W2010438139 countsByYear W20104381392013 @default.
• W2010438139 countsByYear W20104381392014 @default.
• W2010438139 countsByYear W20104381392015 @default.
• W2010438139 countsByYear W20104381392016 @default.
• W2010438139 countsByYear W20104381392017 @default.
• W2010438139 countsByYear W20104381392018 @default.
• W2010438139 countsByYear W20104381392019 @default.
• W2010438139 countsByYear W20104381392020 @default.
• W2010438139 countsByYear W20104381392021 @default.
• W2010438139 countsByYear W20104381392022 @default.
• W2010438139 countsByYear W20104381392023 @default.
• W2010438139 crossrefType "journal-article" @default.
• W2010438139 hasAuthorship W2010438139A5064426920 @default.
• W2010438139 hasAuthorship W2010438139A5078658316 @default.
• W2010438139 hasBestOaLocation W20104381391 @default.
• W2010438139 hasConcept C104317684 @default.
• W2010438139 hasConcept C121608353 @default.
• W2010438139 hasConcept C126322002 @default.
• W2010438139 hasConcept C135763542 @default.
• W2010438139 hasConcept C14184104 @default.
• W2010438139 hasConcept C149737253 @default.
• W2010438139 hasConcept C170493617 @default.
• W2010438139 hasConcept C180754005 @default.
• W2010438139 hasConcept C185592680 @default.
• W2010438139 hasConcept C2778722691 @default.
• W2010438139 hasConcept C2779777798 @default.
• W2010438139 hasConcept C2780820201 @default.
• W2010438139 hasConcept C2780962732 @default.
• W2010438139 hasConcept C2781063702 @default.
• W2010438139 hasConcept C42219234 @default.
• W2010438139 hasConcept C526805850 @default.
• W2010438139 hasConcept C55493867 @default.
• W2010438139 hasConcept C71924100 @default.
• W2010438139 hasConcept C90924648 @default.
• W2010438139 hasConceptScore W2010438139C104317684 @default.
• W2010438139 hasConceptScore W2010438139C121608353 @default.
• W2010438139 hasConceptScore W2010438139C126322002 @default.
• W2010438139 hasConceptScore W2010438139C135763542 @default.
• W2010438139 hasConceptScore W2010438139C14184104 @default.
• W2010438139 hasConceptScore W2010438139C149737253 @default.
• W2010438139 hasConceptScore W2010438139C170493617 @default.

• next